Reuters logo
BRIEF-Trillium Therapeutics reports Q3 results
November 10, 2017 / 12:13 PM / a month ago

BRIEF-Trillium Therapeutics reports Q3 results

Nov 10 (Reuters) - Trillium Therapeutics Inc

* Trillium Therapeutics reports third quarter 2017 financial and operating results

* Trillium Therapeutics Inc - ‍Cash and marketable securities of $64.3 million at September 30, 2017​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below